Merck’s Keytruda could offer ‘paradigm shift’ in lung cancer treatment
Thursday, July 5, 2018 - 18:22
in Health & Medicine
Results from a large Phase III study of the cancer immunotherapy were reported at cancer conference
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via